Cleared Traditional

QUANTA LITE M2 EP (MIT3) ELISA

K052262 · Inova Diagnostics, Inc. · Immunology
Oct 2005
Decision
69d
Days
Class 2
Risk

About This 510(k) Submission

K052262 is an FDA 510(k) clearance for the QUANTA LITE M2 EP (MIT3) ELISA, a Antimitochondrial Antibody, Indirect Immunofluorescent, Antigen, Control (Class II — Special Controls, product code DBM), submitted by Inova Diagnostics, Inc. (San Diego, US). The FDA issued a Cleared decision on October 27, 2005, 69 days after receiving the submission on August 19, 2005. This device falls under the Immunology review panel. Regulated under 21 CFR 866.5090.

Submission Details

510(k) Number K052262 FDA.gov
FDA Decision Cleared SESE
Date Received August 19, 2005
Decision Date October 27, 2005
Days to Decision 69 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Statement

Device Classification

Product Code DBM — Antimitochondrial Antibody, Indirect Immunofluorescent, Antigen, Control
Device Class Class II — Special Controls
CFR Regulation 21 CFR 866.5090

Similar Devices — DBM Antimitochondrial Antibody, Indirect Immunofluorescent, Antigen, Control

All 26
EliA M2 Immunoassay
K181556 · Phadia AB · Jul 2018
QUANTA Flash M2 (MIT3), QUANTA Flash M2 (MIT3) Calibrators, QUANTA Flash M2 (MIT3) Controls
K163525 · Inova Diagnostics, Inc. · Sep 2017
ImmuLisa Enhanced AMA IgG Antibody ELISA; ImmuLisa Enhanced AMA IgA/IgG/IgM Antibody ELISA
K163133 · Immco Diagnostics, Inc. · Aug 2017
ELIA M2; IMMUNOASSAY, POSITIVE CONTROL 100, POSITIVE CONTROL 250
K141375 · Phadia US, Inc. · Feb 2015
EUROIMMUN ANTI-M2-3E ELISA (IGG)
K092736 · Euroimmun Us, Inc. · Sep 2010
RHIGENE MESACUP-2 ANTI-MITOCHONDRIA M2 TEST, MODEL 10760
K031308 · Rhigene, Inc. · Sep 2003